Product image

Vozan Tablets

Vozan Tablets – Rapid Relief for Peptic Ulcers and GERD

Vozan is a specialized gastrointestinal medication containing Vonoprazan Fumurate, a modern potassium-competitive acid blocker (P-CAB). It is primarily indicated for the treatment of various acid-related conditions, including gastric ulcers and duodenal ulcers. Vozan is also highly effective in managing reflux esophagitis, where stomach acid causes inflammation and discomfort in the food pipe. As a P-CAB, Vozan provides faster and more sustained inhibition of stomach acid production than older classes of medications. This rapid action is essential for providing quick symptom relief and creating a stable environment for the healing of irritated or damaged gastric tissues. The medication's efficacy is not significantly affected by food intake, allowing for flexible dosing at any time of the day. Consistent daily use helps prevent the recurrence of ulcers and provides long-term protection for the digestive tract. It is a reliable choice for clinicians seeking robust control of gastric acidity in adult patients.

  • Treats gastric ulcers, duodenal ulcers, and reflux esophagitis.
  • Provides rapid and sustained suppression of stomach acid.
  • Modern P-CAB therapy for improved gastric health.
  • Available as: Tablets 10mg and 20mg.

You may also like

Take it to your cart

Ezole Capsules
Ezole Capsules

Ezole Capsules – Targeted Suppression of Stomach Acid

Ezole Capsules contain Esomeprazole, a potent proton pump inhibitor de...

Risek Capsules
Risek Capsules

Risek Capsules – Comprehensive Acid-Related Disease Management

Risek is a established gastrointestinal treatment used for a...

EN-URA Tablets
EN-URA Tablets

EN-URA Tablets – Targeted Relief for Overactive Bladder

EN-URA is a specialized therapeutic option designed to manage bother...

Saltra Inhaler
Saltra Inhaler

Saltra Inhaler – Comprehensive Respiratory Maintenance Therapy

Saltra Inhaler is a specialized respiratory medication used f...

Image NewsLetter
Icon primary
Newsletter

Subscribe our newsletter

By clicking the button, you are agreeing with our Term & Conditions

Your experience on this site will be improved by allowing cookies Cookie Policy